SELECT COUNTRY

VIEW ALL
AFRICA
AMERICAS
ASIA
EUROPE
OCEANIA

ZAMBIA: LATEST INTERVIEWS MORE INTERVIEWS

Mark Bristow
PRESIDENT & CEO, BARRICK GOLD
"Our successful exploration programs are feeding high-quality prospects into an already bulging pipeline and we expect to grow our reserves net of depletion again this year."
Mining
Canada
United States
Zambia
DRC
Mali
Dominican Republic
MACIG
Pierre Léveillé
PRESIDENT & CEO, DEEP SOUTH RESOURCES
Deep South Resources remains determined to mine its Haib copper project in Namibia.
Mining
Zambia
MACIG
Shahram Tafazoli
FOUNDER AND CEO, MOTION METRICS
Motion Mertics explains how the latest technologies are being deployed in African mines.
Mining
South Africa
Zambia
DRC
Mozambique
Namibia
Niger
Nigeria
Angola
MACIG
Bernard Kaninda
AFRICA REGIONAL DIRECTOR, MAXAM
Maxam offers sophisticated blasting technology that considers all aspects of the conditions, as well as the environment that surrounds them in West Africa.
Mining
Zambia
Cote d’Ivoire
Mali
Ghana
Burkina Faso
Mauritanie
MACIG

ZAMBIA: LATEST ARTICLES

Mining
Botswana
Zimbabwe
Zambia
DRC
Cote d’Ivoire
Senegal
Ghana
Burkina Faso
Angola
MACIG

The Geographic Spread of Africa’s Mining Investors

April 26, 2019
THE OFFICIAL MINING IN AFRICA COUNTRY INVESTMENT GUIDE (MACIG) 2019
International investors demonstrate reinvigorated appetite for Africa’s mining prospects – from traditional partners like the Australians to a growing Chinese and Russian presence.
MORE ARTICLES

ZAMBIA: RECENTLY RELEASED PUBLICATIONS

MACIG 2023 Pre-Release

November 21, 2022

West Africa, Copperbelt and Angola Mining 2021 E&MJ Release

March 05, 2021

MACIG Copperbelt & Angola 2021

January 27, 2021

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

United States Life Sciences 2023

In many ways, 2022 was a turning point for the US life sciences industry. After having provided a lightning-quick response to the Covid-19 pandemic, the industry gathered the lessons learned and sought a sense of normalcy to continue developing necessary drugs for patients worldwide. Yet, the geopolitical, macroeconomic, and regulatory environments all come with their set of challenges, forcing executives into increasingly complex decisions when defining their strategies.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL